Extremity Medical Product Launch Plans for 2017
Extremity Medical’s 2017 product launch plans include systems for Charcot fixation, total wrist arthroplasty, MTP fusion and Jones fracture. Mar 13, 2017
Paragon 28 Launches the Gorilla Calc Fracture Plating System
Paragon 28 launched the Gorilla® Calc Fracture Plating System for the treatment of calcaneal fractures. Mar 13, 2017
DJO Global Launches AltiVate Anatomic Shoulder
DJO Global launched the AltiVate™ Anatomic Shoulder, featuring P2, a proprietary “porous porous” coating designed to provide superior bone ingrowth. Mar 13, 2017
Broader FDA Clearance for Spineology Elite Expandable Interbody Fusion System
Spineology received expanded FDA 510(k) clearance of the Elite Expandable Interbody Fusion system, to include a narrower 10mm version of the device and an indication for use with allograft bone. Mar 13, 2017
Ethicon, DePuy Synthes Launch Wound Closure Kits for Orthopaedic Surgery
Ethicon and DePuy Synthes commenced U.S. launch of wound closure kits customized for orthopaedic surgery, including STRATAFIX™ Knotless Tissue Control Devices and the DERMABOND® PRINEO® Skin Closure System. Mar 13, 2017
Consensus Orthopedics Launches Orthopaedic Post-Surgical Wearable
Consensus Orthopedics launched TracPatch™, a wearable device for real-time, continuous post-surgical remote patient monitoring following total joint replacement. Mar 09, 2017
Second Patent for TheraCell Demineralized Bone Fiber Technology
TheraCell was awarded U.S. Patent Number 9,572,912, “Demineralized Bone Fibers having Controlled Geometry and Shapes and Methods Thereof,” its second U.S. patent for DBF™ technology. Mar 09, 2017
Positive Interim Data from Trial for BonyPid Antibiotic Eluting Bone Substitute
Interim results from study of BonyPid®-1000 bone substitute in the treatment of open tibial fractures indicate that the product met performance and safety endpoints in first patients at 6 months. Mar 09, 2017
Recruitment Status for ALLOB Delayed-Union Study
Bone Therapeutics completed recruitment of 16 patients in the Phase I/IIA delayed-union fracture study of ALLOB® allogeneic cell therapy product. Mar 09, 2017
Study Results: Vitrium Bioactive Glass in Ovine Spinal Fusion
Results from ovine study of Bio2 Technologies’ Vitrium bioactive glass demonstrated the device’s capability to support interbody fusion. Mar 08, 2017
